Levi & Korsinsky, LLP: Cellectra Device Manufacturing Practices at Center of Inovio Pharmaceuticals Securities Litigation

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Inovio Pharmaceuticals, Inc. (NASDAQ: INO) that a class action lawsuit has been filed on behalf of shareholders who purchased securities between October 10, 2023 and December 26, 2025. Click here to learn more about this case You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500. The Alleged CELLECTRA Device Manufacturing Deficiencies The biotechnology sector relies heavily on medical dev ...